TrialESMO open2022

External control cohorts for the single-arm LIBRETTO-001 trial of selpercatinib in RET+ non-small-cell lung cancer.

C Rolfo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.